I-Therapeutix Raises $6 Million

I-Therapeutix Inc., a Waltham, Mass.-based developer of situ formed hydrogel therapeutic products for ophthalmology, has raised $6 million in Series B funding, according to VentureWire. SV Life Sciences and Versant Ventures co-led the round. www.itherapeutix.com